Cargando…

A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis

Immunotherapy, a treatment based on host immune system activation, has been shown to provide a substitute for marginally effective conventional chemotherapy in controlling visceral leishmaniasis (VL), the deadliest form of leishmaniasis. As the majority of endemic inhabitants exhibit either subclini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ratnapriya, Sneha, Keerti, Yadav, Narendra Kumar, Dube, Anuradha, Sahasrabuddhe, Amogh Anant
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164546/ https://www.ncbi.nlm.nih.gov/pubmed/34095312 http://dx.doi.org/10.1155/2021/8845826

Ejemplares similares

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani
por: Joshi, Sumit, et al.
Publicado: (2019)

Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis
por: Gupta, Reema, et al.
Publicado: (2014)

Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani
por: Joshi, Sumit, et al.
Publicado: (2016)

Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters
por: Baharia, Rajendra K., et al.
Publicado: (2014)

Correction: Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters
por: Baharia, Rajendra K., et al.
Publicado: (2021)

Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2015)

Th1 Stimulatory Proteins of Leishmania donovani: Comparative Cellular and Protective Responses of rTriose Phosphate Isomerase, rProtein Disulfide Isomerase and rElongation Factor-2 in Combination with rHSP70 against Visceral Leishmaniasis
por: Jaiswal, Anil Kumar, et al.
Publicado: (2014)

Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis
por: Kumar, Prabin, et al.
Publicado: (2019)

Over-Expression of 60s Ribosomal L23a Is Associated with Cellular Proliferation in SAG Resistant Clinical Isolates of Leishmania donovani
por: Das, Sanchita, et al.
Publicado: (2013)

Cloning, Expression and Purification of L. Donovani Specific Antigen for Serodiagnosis of Visceral Leishmaniasis
por: Kumar, Dinesh, et al.
Publicado: (2013)

Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches
por: Joshi, Sumit, et al.
Publicado: (2014)

Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis
por: Kushawaha, Pramod K., et al.
Publicado: (2012)

Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
por: Kushawaha, Pramod Kumar, et al.
Publicado: (2012)

Leishmania donovani and Cutaneous Leishmaniasis, Sri Lanka
por: Siriwardana, H. V. Yamuna D., et al.
Publicado: (2007)

Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016)

Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis
por: Baharia, Rajendra K, et al.
Publicado: (2015)

Histopathology of Cutaneous Leishmaniasis Caused by Leishmania donovani in Sri Lanka
por: Wijesinghe, Harshima, et al.
Publicado: (2020)

Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
por: Zijlstra, Eduard E.
Publicado: (2021)

Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis
por: Islamuddin, Mohammad, et al.
Publicado: (2016)

The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with Leishmania donovani
por: Rostan, Octavie, et al.
Publicado: (2013)

Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
por: Anand, Sneha, et al.
Publicado: (2015)

Synergistic Effect of Various Regulatory Factors in Th1/Th2 Balance; Immunotherapeutic Approaches in Asthma
por: Lee, Young-Cheol
Publicado: (2008)

Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani
por: Duthie, Malcolm S, et al.
Publicado: (2019)

Exploring the Immunotherapeutic Potential of Oleocanthal against Murine Cutaneous Leishmaniasis
por: Karampetsou, Kalliopi, et al.
Publicado: (2022)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice
por: Melo, Guilherme D., et al.
Publicado: (2017)

Distinct microbiome profiles and biofilms in Leishmania donovani-driven cutaneous leishmaniasis wounds
por: Jayasena Kaluarachchi, T. D., et al.
Publicado: (2021)

Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani
por: Wijesooriya, Hiruni, et al.
Publicado: (2023)

Diagnostic Tools for Cutaneous Leishmaniasis Caused by Leishmania donovani: A Narrative Review
por: Piyasiri, Sachee Bhanu, et al.
Publicado: (2023)

Leishmania donovani persistence and circulation causing cutaneous leishmaniasis in unusual-foci of Nepal
por: Rai, Tinmaya, et al.
Publicado: (2023)

Structural insights into kinetoplastid coronin oligomerization domain and F-actin interaction
por: Parihar, Pankaj Singh, et al.
Publicado: (2021)

Evidence for Seroprevalence in Human Localized Cutaneous Leishmaniasis Caused by Leishmania donovani in Sri Lanka
por: Siriwardana, Yamuna Deepani, et al.
Publicado: (2018)

Assessment of intralesional cytokine profile of cutaneous leishmaniasis caused by Leishmania donovani in Sri Lanka
por: Galgamuwa, Lahiru Sandaruwan, et al.
Publicado: (2019)

Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis
por: Jamal, Fauzia, et al.
Publicado: (2017)

Visceral Leishmaniasis Caused by Leishmania donovani Zymodeme MON-37, Western Ghats, India
por: Saini, Prasanta, et al.
Publicado: (2020)

Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients
por: Marlais, Tegwen, et al.
Publicado: (2020)

Leishmania donovani Induced Cutaneous Leishmaniasis: An Insight into Atypical Clinical Variants in Sri Lanka
por: Siriwardana, Yamuna, et al.
Publicado: (2019)

Hesperidin Targets Leishmania donovani Sterol C-24 Reductase to Fight against Leishmaniasis
por: Tabrez, Shams, et al.
Publicado: (2021)

Livestock and rodents within an endemic focus of Visceral Leishmaniasis are not reservoir hosts for Leishmania donovani
por: Kushwaha, Anurag Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rv9k7026hc2ens0vgebk7cjgjc